-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Okta, Enservco, CareDx, and Spero and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
-
-
-
-
-
-
-
Spero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 Conference
-
-
-
-
-
-
-
Spero Announces Appointment of David P. Southwell to its Board of Directors
-
-
-
-
-
-
1,154,842 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

